|
May 7
|
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
|
|
Mar 19
|
PureTech Proposes $100 Million Capital Return
|
|
Dec 22
|
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
|
|
Dec 20
|
PureTech Year End Update and Outlook for 2024
|
|
Dec 7
|
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
|
|
Nov 29
|
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
|
|
Nov 14
|
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
|
|
Aug 22
|
PureTech Health: Notice of Half-Yearly Results
|
|
May 4
|
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
|
|
Apr 29
|
Full Year 2023 PureTech Health PLC Earnings Call
|